v3.26.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2026
Dec. 31, 2025
Current assets:    
Cash and cash equivalents $ 27,329,415 $ 30,806,477
Accounts receivable 245,100 0
Prepaid expenses and other current assets 571,544 184,827
Total current assets 28,146,059 30,991,304
Goodwill 9,600,240 9,600,240
In-process research and development 4,800,000 4,800,000
Property and equipment, net 14,878 8,340
Right-of-use asset 143,677 184,229
Other non-current assets 0 18,996
Total assets 42,704,854 45,603,109
Current liabilities:    
Accounts payable 852,367 624,995
Accrued liabilities and other current liabilities 1,649,987 2,608,021
Deferred revenue 428,276 370,160
Operating lease liability 165,198 194,331
Total current liabilities 3,095,828 3,797,507
Deferred tax liability 201,792 201,792
Other non-current liabilities 0 17,129
Total liabilities 3,297,620 4,016,428
Commitments and contingencies (Note 4)
Stockholders’ equity:    
Common stock, $0.001 par value; 100,000,000 shares authorized at March 31, 2026 and December 31, 2025; 49,221,246 and 49,221,246 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively 49,221 49,221
Additional paid-in capital 480,821,600 480,413,839
Accumulated other comprehensive loss (128,130) (127,180)
Accumulated deficit (441,335,457) (438,749,199)
Total stockholders’ equity 39,407,234 41,586,681
Total liabilities and stockholders' equity $ 42,704,854 $ 45,603,109